Literature DB >> 12642824

Hygiene hypothesis: fact or fiction?

Andrew H Liu1, James R Murphy.   

Abstract

The hygiene hypothesis of asthma and allergy has recently received a swell of popularity and published supporting evidence, and has been extended to autoimmune conditions of childhood. Broadly stated, naturally occurring infections and microbial exposures might essentially immunize against the development of asthma and allergic and autoimmune diseases. If true, then reductions in nature's immunotherapy over the past century might be a major factor in the global increase of these conditions (eg, the higher prevalence of asthma and allergies in urban metropolitan areas compared with rural and farm communities) and might lead to new therapies for these conditions. Although such a unifying hypothesis has great appeal, currently it is only speculation about what might be at the end of the investigative road. How close are the current studies to establishing a causal relationship between microbial exposures and a reduction in allergic, asthmatic, and autoimmune disease prevalence? A systematic epidemiologic appraisal of the current hygiene hypothesis evidence can provide a critical analysis of what is currently known and an investigative blueprint for future studies that can ultimately prove causation and improve recommendations, interventions, and therapies.

Entities:  

Mesh:

Year:  2003        PMID: 12642824     DOI: 10.1067/mai.2003.172

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  29 in total

1.  Prevention strategies for asthma--secondary prevention.

Authors: 
Journal:  CMAJ       Date:  2005-09-13       Impact factor: 8.262

Review 2.  The two sides of the "endotoxin coin".

Authors:  K Radon
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

3.  Effect of day care attendance on sensitization and atopic wheezing differs by Toll-like receptor 2 genotype in 2 population-based birth cohort studies.

Authors:  Adnan Custovic; Janet Rothers; Debbie Stern; Angela Simpson; Ashley Woodcock; Anne L Wright; Nicolaos C Nicolaou; Jenny Hankinson; Marilyn Halonen; Fernando D Martinez
Journal:  J Allergy Clin Immunol       Date:  2011-02       Impact factor: 10.793

4.  Using house dust extracts to understand the immunostimulatory activities of living environments.

Authors:  Glenda Batzer; Diane P Lam; Petra Paulus; Jared Boasen; Nicholas Ng; Anthony A Horner
Journal:  Immunobiology       Date:  2007-04-30       Impact factor: 3.144

5.  Time Trends in Racial and Ethnic Disparities in Asthma Prevalence in the United States From the Behavioral Risk Factor Surveillance System (BRFSS) Study (1999-2011).

Authors:  Nandita Bhan; Ichiro Kawachi; Maria M Glymour; S V Subramanian
Journal:  Am J Public Health       Date:  2014-10-16       Impact factor: 9.308

6.  Child health in the United States: recent trends in racial/ethnic disparities.

Authors:  Neil K Mehta; Hedwig Lee; Kelly R Ylitalo
Journal:  Soc Sci Med       Date:  2012-09-17       Impact factor: 4.634

7.  Respiratory virus-induced regulation of asthma-like responses in mice depends upon CD8 T cells and interferon-gamma production.

Authors:  Joost J Smit; Louis Boon; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

Review 8.  Defining a role for ambient TLR ligand exposures in the genesis and prevention of allergic diseases.

Authors:  Kevin Tse; Anthony A Horner
Journal:  Semin Immunopathol       Date:  2007-11-08       Impact factor: 9.623

Review 9.  Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis.

Authors:  Robert C Kern; David B Conley; William Walsh; Rakesh Chandra; Atsushi Kato; Anju Tripathi-Peters; Leslie C Grammer; Robert P Schleimer
Journal:  Am J Rhinol       Date:  2008-09-10

10.  The danger is growing! A new paradigm for immune system activation and peripheral tolerance.

Authors:  Sharon Bewick; Ruoting Yang; Mingjun Zhang
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.